Health Tech Capitol | Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase
15778
post-template-default,single,single-post,postid-15778,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase

21 Feb Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase

Posted at 16:02h in Uncategorized by
0 Likes

MADISON, Wis., Feb. 21, 2017 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $99.4 million and completed approximately 244,000 Cologuard tests during the year ended Dec. 31, 2016. Full-year 2016 revenues and Cologuard test volume grew 152 percent and 135 percent from 2015, respectively.

During the fourth quarter of 2016, the company generated revenues of $35.2 million and completed approximately 82,000 Cologuard tests. Fourth-quarter 2016 revenues and test volume grew 144 percent and 114 percent from the same period of 2015, respectively.

“Cologuard’s strong performance during 2016 reflects the accelerating demand for our non-invasive colon cancer screening test and positions us well for long-term, sustainable growth,” said Kevin Conroy, chairman and CEO of Exact Sciences. “Our annual revenue met the high end of our original expectations for 2016.”

Read more at exactsciences.com

No Comments

Sorry, the comment form is closed at this time.